IndiaMart
FIEO
Retatrutide 50mg is a next-generation, ultra-high potency triple hormone receptor agonist peptide, developed to target GLP-1, GIP, and glucagon receptors simultaneously. This advanced peptide formulation promotes fat reduction, appetite regulation, energy optimization, and metabolic balance, making it a cutting-edge solution in obesity management, metabolic therapy, and research applications.
BLUEPILL EXPRESS, a globally recognized merchant exporter, supplies Retatrutide 50mg manufactured in GMP-certified facilities across India and China, offering clients flexibility in sourcing and compliance. Each batch undergoes stringent purity, potency, and stability testing, ensuring pharmaceutical-grade quality that aligns with international export standards.
Key Features of Retatrutide 50mg:
- High-strength triple agonist peptide (GLP-1, GIP, Glucagon receptors)
- Enhances fat metabolism, energy balance, and glucose regulation
- Promotes weight control and metabolic health
- GMP-certified manufacturing in India and China
- Exported worldwide by BLUEPILL EXPRESS – trusted merchant exporter
- Suitable for research, wellness, and pharmaceutical applications
- Supplied with COA, batch documentation, and export compliance certificates
- Available for bulk orders, OEM production, and private labeling
BLUEPILL EXPRESS ensures that each vial of Retatrutide 50mg meets global pharmaceutical quality standards, backed by comprehensive analytical documentation. Our export operations manage custom labeling, packaging, and regulatory logistics, ensuring seamless delivery across markets.
With manufacturing units in India and China, BLUEPILL EXPRESS delivers cost efficiency, consistent supply, and regulatory assurance. As a leading merchant exporter, we specialize in premium peptides like Retatrutide 50mg, catering to the metabolic wellness, pharmaceutical, and research sectors worldwide.
